Light Therapy Device Tested Against Long COVID Brain Fog in Remote RCT
A double-blind trial tests whether 810nm photobiomodulation can reverse cognitive impairment in long COVID patients at home.
20 articles
A double-blind trial tests whether 810nm photobiomodulation can reverse cognitive impairment in long COVID patients at home.
Clinical trial explores how targeted light treatment could restore circadian rhythms and improve brain function in mild cognitive impairment.
Small trial tests psychedelic therapy combined with meditation for frontline healthcare providers suffering COVID-related burnout.
60-person study tested psilocybin alone and with CBT for major depression, measuring brain activity and inflammatory markers.
A completed RCT tested whether a CBT-based smartphone app reduces moderate depression versus an active placebo in 158 participants; outcomes are not reported in the registration record.
Swiss researchers tested LSD-assisted therapy for anxiety disorders in a controlled crossover trial with 46 participants.
Small doses of psilocybin tested against placebo in 39 adults with major depressive disorder to assess safety and mood benefits.
Small study tests psychedelic compound's safety and effectiveness against severe depression that doesn't respond to standard treatments.
Eight-week mindfulness program tested for women experiencing severe menopause symptoms after preventive ovary removal surgery.
German researchers test whether digital environmental enrichment can boost mental and physical wellbeing in seniors through telehealth.
Pilot study tests psilocybin-assisted psychotherapy to help hospice patients overcome demoralization and existential suffering.
Swiss researchers tested whether paroxetine reduces LSD response by downregulating serotonin receptors in healthy adults.
TONTT2 tests whether erythropoietin dose and timing can be optimized to best preserve vision after traumatic optic neuropathy.
UC San Diego researchers tested psilocybin's safety and potential benefits for eating disorder symptoms in 16 participants with anorexia nervosa.
A pilot RCT tested whether a smartphone app could improve quality of life and treatment adherence in HIV-positive patients aged 60+.
A completed RCT tests whether treating insomnia with CBT-I can improve cognition and slow amyloid buildup in adults aged 60โ85.
A completed Mount Sinai RCT tested whether HBOT can improve brain blood flow and cognition in diabetic elders with mild cognitive impairment.
French pilot study tests psychedelic therapy for patients with alcohol use disorder and comorbid depression after withdrawal.
A Phase 4 RCT tests whether one bevacizumab injection matches two combined doses for neovascular AMD outcomes over 12 months.
Small Yale study tested magic mushroom compound for chronic headaches after brain injury, tracking symptoms and inflammation markers.